Related Experiment Video

Updated: Jul 14, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Isothiocyanate E-4IB induces MAPK activation, delayed cell cycle transition and apoptosis

J Bodo1, J Duraj, J Jakubikova

  • 1Laboratory of Tumour Immunology, Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Republic.

Cell Proliferation
|May 29, 2007
PubMed
Abstract

Insights

Synthetic isothiocyanate E-4IB activates cancer cell signaling pathways, leading to cell cycle arrest and apoptosis. This suggests E-4IB has potential anticancer properties by inducing programmed cell death in leukemia cells.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Epidemiologic studies link isothiocyanate-rich foods to reduced cancer risk.
  • Isothiocyanates are naturally occurring compounds with potential chemopreventive properties.

Purpose of the Study:

  • To investigate the effects of synthetic isothiocyanate E-4IB on cancer cell signaling pathways.
  • To elucidate the mechanism of E-4IB-induced cell cycle arrest and apoptosis in leukemia cells.

Main Methods:

  • Utilized synchronized leukaemic HL60 cells.
  • Analyzed the activation of mitogen-activated protein kinases (MAPKs) pathways.
  • Assessed cell cycle progression, mitochondrial membrane potential, and DNA damage.

Main Results:

  • E-4IB activated ERK1/2, c-Jun N-terminal kinase, and p38 signaling pathways.
  • Observed delayed cell cycle transition, rapid cell cycle arrest, and diminished mitochondrial membrane potential.
  • Detected histone deacetylase inhibition, increased DNA double-strand breaks (H2AX phosphorylation), and p21 up-regulation.

Conclusions:

  • E-4IB induces cell cycle arrest and apoptosis in leukemia cells.
  • MAPK pathway activation is a key mechanism in E-4IB's anticancer effects.
  • E-4IB demonstrates potential as an anticancer agent through apoptosis induction.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cellular Injury IlI: Cellular Death01:11

Cellular Injury IlI: Cellular Death

Cell death is the irreversible loss of cellular structure and function, representing the final stage of severe injury. It plays a key role in both normal physiology and disease.Types of Cell DeathThe two main types are necrosis and apoptosis, though others like necroptosis and pyroptosis also exist.Necrosis:Necrosis is an unregulated form of cell death caused by severe injury such as trauma, toxins, or ischemia. It is characterized by cell swelling, membrane loss, rupture, and leakage of...